Search results

Measurement of fibrinogen in plasma. Detection of low fibrinogen concentrations. Detection of elevated fibrinogen concentrations (> 4g/L): In clinical situations associated with inflammation Risk factor for cardiovascular disease and thrombosis Hypofibrinogenemia, mainly associated with severe liver disease, and excessive consumption of fibrinogen (DIC, hyperfibrinolysis). Numerous variants of fibrinogen described, associated to asymptomatic cases, or to cases with bleeding and/or thrombosis.

Determination of prothrombin time (PT) in human citrated plasma.

Determination of prothrombin time (PT) in human citrated plasma.

Determination of prothrombin time (PT) in human citrated plasma.

Determination of prothrombin time (PT) in human citrated plasma with ready-for-use liquid reagents.

Determination of prothrombin time (PT) in human citrated plasma with ready-for-use liquid reagents.

Determination of prothrombin time (PT) in human citrated plasma with ready-for-use liquid reagents.

Determination of prothrombin time (PT) in human citrated plasma with ready-for-use liquid reagents.

Recommended for all research protocols where a source of highly purified and characterized thrombin is necessary, and studies on anti-thrombin activities.

Measurement of Factor II (FII / prothrombin) activity in human citrated plasma using a clotting method, triggered with calcium thromboplastin. For any in vitro protocol or research study where a source of human prothrombin deficient plasma is required.